Katie Bailey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katie Bailey has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Bradley Ray
RTI International, Research Triangle Park, USA
6 shared publications - Steffanie A. Strathdee
School of Medicine, University of California San Diego, La Jolla, California, USA
5 shared publications Carlos F. Vera
School of Medicine, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA
4 shared publications- Peter J. Davidson
School of Medicine, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA
4 shared publications - Angela Robertson Bazzi
Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, USA
3 shared publications - Daniela Abramovitz
School of Medicine, University of California San Diego, La Jolla, California, USA
3 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 287
Multilevel drivers and constraints of shifts from injecting to smoking opioids and stimulants: A qualitative study from the San Diego-Tijuana border region
- 28 July 2026
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 287
Open AccessMultilevel drivers and constraints of shifts from injecting to smoking opioids and stimulants: A qualitative study from the San Diego-Tijuana border region
- Open Access
- 24 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0334978
Harm reduction services and interventions for People Who Use Drugs (PWUD) in Latin America and the Caribbean (LAC) between 2013–2024: A scoping review protocol
Introduction: In Latin America and the Caribbean (LAC) the response to substance use has primarily been abstinence-based, acute-care-oriented treatments. While harm reduction services (HRS) and interventions have expanded in LAC over the last decade, the research evidence on such programs has been sparse and disjointed. Objective: This scoping review will map peer-reviewed literature on HRS and interventions in LAC, and synthesize gaps and opportunities for policy, practice, and research. Inclusion criteria: Studies conducted in LAC. The HRS that will be included in the search are opioid agonist therapy, syringe services programs, drug consumption facilities, safer consumption kits, managed alcohol programs, and drug-checking services. The scoping review will consider peer-reviewed original research, including qualitative, quantitative, and mixed-methods designs. We will exclude studies addressing harms associated with nicotine or tobacco use. We included original research written in English, Spanish, Portuguese, or French published between January 2013 and December 2024. Methods: We will conduct literature searches in English (PubMed, Scopus, Web of Science), Spanish, Portuguese (SciELO and BIREME), and French (BIREME). Two reviewers will independently screen the literature. Extraction of characteristics of the studies using a template in Covidence. Data on the HRS and interventions studied and implemented in LAC will be summarized and presented in tables, graphs, and a narrative summary. We will use a narrative synthesis approach to summarize implications for policy, research, and practice identified in the literature. The review was registered in Open Science Framework ( https://osf.io/qya7c/ ), Discussion: The proposed scoping review will provide valuable information regarding the current state of HRS and interventions for PWUD in LAC. This in return can help guide future research for evaluating services that are already being implemented or unveil services needed in the region. To our knowledge, this is the first scoping review to map HRS in LAC using a systematic approach. Furthermore, among the strengths of this review are: the broad number of services, countries, and time, as well as the consultation with experts and knowledge users.
- 24 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0334978
Open AccessHarm reduction services and interventions for People Who Use Drugs (PWUD) in Latin America and the Caribbean (LAC) between 2013–2024: A scoping review protocol
Introduction: In Latin America and the Caribbean (LAC) the response to substance use has primarily been abstinence-based, acute-care-oriented treatments. While harm reduction services (HRS) and interventions have expanded in LAC over the last decade, the research evidence on such programs has been sparse and disjointed. Objective: This scoping review will map peer-reviewed literature on HRS and interventions in LAC, and synthesize gaps and opportunities for policy, practice, and research. Inclusion criteria: Studies conducted in LAC. The HRS that will be included in the search are opioid agonist therapy, syringe services programs, drug consumption facilities, safer consumption kits, managed alcohol programs, and drug-checking services. The scoping review will consider peer-reviewed original research, including qualitative, quantitative, and mixed-methods designs. We will exclude studies addressing harms associated with nicotine or tobacco use. We included original research written in English, Spanish, Portuguese, or French published between January 2013 and December 2024. Methods: We will conduct literature searches in English (PubMed, Scopus, Web of Science), Spanish, Portuguese (SciELO and BIREME), and French (BIREME). Two reviewers will independently screen the literature. Extraction of characteristics of the studies using a template in Covidence. Data on the HRS and interventions studied and implemented in LAC will be summarized and presented in tables, graphs, and a narrative summary. We will use a narrative synthesis approach to summarize implications for policy, research, and practice identified in the literature. The review was registered in Open Science Framework ( https://osf.io/qya7c/ ), Discussion: The proposed scoping review will provide valuable information regarding the current state of HRS and interventions for PWUD in LAC. This in return can help guide future research for evaluating services that are already being implemented or unveil services needed in the region. To our knowledge, this is the first scoping review to map HRS in LAC using a systematic approach. Furthermore, among the strengths of this review are: the broad number of services, countries, and time, as well as the consultation with experts and knowledge users.
- Open Access
- 12 February 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 269, 112591
Naloxone distribution amidst shifting drug use patterns: Insights from a needs-based syringe services program
- 12 February 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 269, 112591
Open AccessNaloxone distribution amidst shifting drug use patterns: Insights from a needs-based syringe services program
- Open Access
County by county estimation of possible deaths averted, infections averted, and cost savings of overdose prevention centers in the United States from July 2019-June 2025
Overdose prevention centers (OPCs), also known as safer injection facilities (SIFs) or supervised consumption sites (SCSs), are a service that allows people to obtain sterile supplies to use their own drugs in a safe environment that is monitored by professionals trained in overdose response and harm reduction. Though still illegal under federal law in the U.S. (“Maintaining Drug-Involved Premises”; “United States v. Safehouse”, 2021), many legal or quasi-legal (including some in the U.S.) OPCs have operated since the 1980s. Using CDC overdose death estimates and U.S. Census Bureau population data, we developed a retrospective, scenario-based modeling tool, estimating that 1,329-5,316 deaths could have been averted between July 2019 and June 2025 if 1 out of 100-400 injections had taken place at an OPC. Under these assumptions, 26-105 HIV transmissions and 5,723-22,892 Hepatitis C transmissions could have been averted. Factoring in both discounted lifetime costs to treat those infections as well as the statistical value of deaths averted, $11.9-47.7 billion could have been saved. These data support OPCs as one viable public health intervention to avert deaths and avoid infections. We created a web application that allows users to explore county-level model results and alter model assumptions, including variables like the percent of injections that occur at an OPC.
Open AccessCounty by county estimation of possible deaths averted, infections averted, and cost savings of overdose prevention centers in the United States from July 2019-June 2025
Overdose prevention centers (OPCs), also known as safer injection facilities (SIFs) or supervised consumption sites (SCSs), are a service that allows people to obtain sterile supplies to use their own drugs in a safe environment that is monitored by professionals trained in overdose response and harm reduction. Though still illegal under federal law in the U.S. (“Maintaining Drug-Involved Premises”; “United States v. Safehouse”, 2021), many legal or quasi-legal (including some in the U.S.) OPCs have operated since the 1980s. Using CDC overdose death estimates and U.S. Census Bureau population data, we developed a retrospective, scenario-based modeling tool, estimating that 1,329-5,316 deaths could have been averted between July 2019 and June 2025 if 1 out of 100-400 injections had taken place at an OPC. Under these assumptions, 26-105 HIV transmissions and 5,723-22,892 Hepatitis C transmissions could have been averted. Factoring in both discounted lifetime costs to treat those infections as well as the statistical value of deaths averted, $11.9-47.7 billion could have been saved. These data support OPCs as one viable public health intervention to avert deaths and avoid infections. We created a web application that allows users to explore county-level model results and alter model assumptions, including variables like the percent of injections that occur at an OPC.
- 14 September 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 133, 104577
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs
- 14 September 2024
- Published by Elsevier in International Journal of Drug Policy
- Vol. 133, 104577
A mixed methods study to inform fatal overdose prevention in San Diego, California: Perspectives from people who use drugs
- 26 July 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (11) , 3629-3642
Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region
Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.
- 26 July 2024
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (11) , 3629-3642
Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region
Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.
- Open Access
Safe Injection Self-Efficacy is associated with HCV and HIV seropositivity among people who inject drugs in the San Diego-Tijuana border region
Background Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. Methods PWID were recruited via street outreach for a longitudinal cohort study from October 2020 – September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE scores (low, medium, high) using ordinal logistic regression. Results Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. Conclusions We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to intervene upon the risk environment.
Open AccessSafe Injection Self-Efficacy is associated with HCV and HIV seropositivity among people who inject drugs in the San Diego-Tijuana border region
Background Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. Methods PWID were recruited via street outreach for a longitudinal cohort study from October 2020 – September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE scores (low, medium, high) using ordinal logistic regression. Results Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. Conclusions We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to intervene upon the risk environment.
- Top Cited Papers
- 24 February 2024
- Published by Elsevier in Social Science & Medicine
- Vol. 345, 116723
Police-mental health co-response versus police-as-usual response to behavioral health emergencies: A pragmatic randomized effectiveness trial
- 24 February 2024
- Published by Elsevier in Social Science & Medicine
- Vol. 345, 116723
Top Cited PapersPolice-mental health co-response versus police-as-usual response to behavioral health emergencies: A pragmatic randomized effectiveness trial
- Open Access
- 7 June 2023
- Published by Elsevier in International Journal of Drug Policy
- Vol. 118, 104086
Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California
- 7 June 2023
- Published by Elsevier in International Journal of Drug Policy
- Vol. 118, 104086
Open AccessDrug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California